Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
EDT.TOthis companySpectral Medical Inc.	CA$1.16	-8.47×	-5.93×	169.36×	-10.19×	-125.9%	-211.1%	-478.5%	-1953.0%	68.4%	26.8%	-2.3%	-0.3×	-0.4×	-2.26×	0.08×	0.0%	2	-136.84	2	C
ACB.TOAurora Cannabis Inc.	CA$7.44	-2.13×	0.51×	0.81×	-1.15×	-669.8%	5.2%	-50.8%	-38.0%	-23.8%	-30.2%	-13.9%	0.05×	0.6×	-89.99×	5.94×	0.0%	1	-12.15	2	C+
CPH.TOCipher Pharmaceuticals Inc.	CA$13.57	10.06×	2.22×	5.44×	11.52×	423.7%	65.8%	32.7%	54.2%	22.1%	12.8%	10.8%	0.04×	-0.08×	14.17×	1.12×	0.0%	6	9.06	5	S-
EPRX.TOEupraxia Pharmaceuticals Inc.	CA$10.34	-9.83×	5.04×	0×	-8.54×	-78.4%	0.0%	0.0%	0.0%	-47.9%	-48.6%	-7.2%	0×	2.07×	0×	15.12×	0.0%	2	34.16	2	C
HITI.VHigh Tide Inc.	CA$3.74	-7.06×	4.11×	0.61×	-33.62×	183.6%	25.8%	2.6%	-8.5%	-57.9%	5.6%	3.7%	1.71×	-7.42×	1.15×	1.37×	0.4%	2	1.74	2	C+
PRN.TOProfound Medical Corp.	CA$10.49	-5.48×	3.58×	14.48×	-4.4×	-580.0%	70.8%	-256.3%	-264.4%	-65.3%	-31.1%	-16.5%	0.07×	1.33×	0×	12.52×	0.0%	3	4.37	1	C-
Peer median	—	-5.48×	3.58×	0.81×	-4.4×	-78.4%	25.8%	0.0%	-8.5%	-47.9%	-30.2%	-7.2%	0.05×	0.6×	0×	5.94×	0.0%	2	4.37	2	—